Indu Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Indu Singh has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Shikha Baghel Chauhan
Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, 201313, India
50 shared publications - Chirag Jain
Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, 201313, India
26 shared publications Shikha Baghel Chauhan
Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India
16 shared publicationsChirag Jain
Amity Institute of Pharmacy-AIP, Amity University, Noida, Uttar Pradesh, 201313, India
13 shared publicationsRajan Swami
Chitkara College of Pharmacy, Chitkara University, Punjab, India
5 shared publicationsSimran Nayan
Amity Institute of Pharmacy, Amity University, Noida, UP, 201313, India
4 shared publications
Latest Publications
- 24 September 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32, 1-10
Emulsomes in Cancer Therapy: Emerging Advances in Nanomedicine
Cancer is a leading cause of death worldwide and continues to pose significant challenges in treatment. Poor drug solubility, non-specific distribution, MDR, and systemic toxicity remain some of the major concerns regarding treatment efficacy. Emulsomes represent a promising drug delivery platform that helps overcome some of these limitations, acting as hybrid nanocarrier systems that incorporate the advantages of liposomes and solid lipid nanoparticles. This article provides an overview of the composition, structure, and physicochemical properties of emulsomes, their advantages over conventional nanocarriers, and a detailed discussion of their role in cancer treatment. The authors discuss a variety of medicinal substances, including chemotherapeutic drugs and natural chemicals, that are delivered using emulsomes. Current research highlights the potential application of emulsomes across a wide range of cancers, including colon, brain, lung, prostate, breast, and hematologic malignancies. These features are compared with those of other nanocarriers with respect to composition, size (nm), stability, tumor-targeting capacity, biocompatibility, and toxicity. In addition, this work further highlights the current in vitro and in vivo evaluations of emulsomes, along with a thorough discussion of formulation challenges, scaling issues, and regulatory considerations. Lastly, this study covers recent advancements and potential future applications, including AI-enabled surface modification for targeted distribution, personalized medication, theragnostic applications, and emulsome design optimization. Overall, this study provides a strong foundation for understanding the current and future potential of emulsomes in managing various types of cancer.
- 24 September 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32, 1-10
Emulsomes in Cancer Therapy: Emerging Advances in Nanomedicine
Cancer is a leading cause of death worldwide and continues to pose significant challenges in treatment. Poor drug solubility, non-specific distribution, MDR, and systemic toxicity remain some of the major concerns regarding treatment efficacy. Emulsomes represent a promising drug delivery platform that helps overcome some of these limitations, acting as hybrid nanocarrier systems that incorporate the advantages of liposomes and solid lipid nanoparticles. This article provides an overview of the composition, structure, and physicochemical properties of emulsomes, their advantages over conventional nanocarriers, and a detailed discussion of their role in cancer treatment. The authors discuss a variety of medicinal substances, including chemotherapeutic drugs and natural chemicals, that are delivered using emulsomes. Current research highlights the potential application of emulsomes across a wide range of cancers, including colon, brain, lung, prostate, breast, and hematologic malignancies. These features are compared with those of other nanocarriers with respect to composition, size (nm), stability, tumor-targeting capacity, biocompatibility, and toxicity. In addition, this work further highlights the current in vitro and in vivo evaluations of emulsomes, along with a thorough discussion of formulation challenges, scaling issues, and regulatory considerations. Lastly, this study covers recent advancements and potential future applications, including AI-enabled surface modification for targeted distribution, personalized medication, theragnostic applications, and emulsome design optimization. Overall, this study provides a strong foundation for understanding the current and future potential of emulsomes in managing various types of cancer.
- 14 September 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32, 1-12
Smart Cosmetic Formulation: A Systematic Review of AI-Powered Approaches
Introduction: Cosmetics and cosmeceuticals serve both aesthetic and hygienic functions, yet traditional formulation approaches remain resource-intensive, empirical in nature, and limited in their capacity for personalisation. The integration of artificial intelligence (AI) and machine learning (ML) into cosmetic science offers a transformative alternative, enabling faster ingredient screening, predictive safety and efficacy assessment, and individualised product design. Methods: A systematic literature search was conducted across PubMed/MEDLINE, Google Scholar, ScienceDirect, IEEE Xplore, ResearchGate, and Google Patents, covering publications from 2013 to March 2025. Search terms spanned AI-driven formulation design, predictive modelling, ingredient optimisation, toxicity prediction, personalised skincare, and regulatory considerations. Peer-reviewed articles, technical studies, and patents meeting pre-defined inclusion criteria were selected. Results: This review systematically examines AI and ML applications across the cosmetic formulation pipeline from ingredient selection and stability prediction to toxicity screening, safety assessment, and personalised recommendation systems. Discussion: Unlike previous reviews that primarily address diagnostic or imaging applications, this work's particular emphasis is on formulation science: predictive modelling of preservative efficacy, in silico toxicity assessment using quantitative structure-activity relationship (QSAR) and read-across tools, AI-assisted skin analysis, and the algorithmic frameworks underpinning these advances. Comparative discussion of convolutional neural networks (CNN), artificial neural networks (ANN), support vector machines (SVM), random forests, and gradient boosting approaches contextualises their strengths and limitations within cosmetic applications. Conclusion: AI and ML are reshaping cosmetic formulation from an empirical, trial-and-error process into a data-driven, predictive discipline. While challenges related to data quality, algorithmic bias, regulatory harmonisation, and validation remain, the trajectory indicates that AI will become an indispensable partner in designing safer, more effective, and more personalised cosmetic products.
- 14 September 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32, 1-12
Smart Cosmetic Formulation: A Systematic Review of AI-Powered Approaches
Introduction: Cosmetics and cosmeceuticals serve both aesthetic and hygienic functions, yet traditional formulation approaches remain resource-intensive, empirical in nature, and limited in their capacity for personalisation. The integration of artificial intelligence (AI) and machine learning (ML) into cosmetic science offers a transformative alternative, enabling faster ingredient screening, predictive safety and efficacy assessment, and individualised product design. Methods: A systematic literature search was conducted across PubMed/MEDLINE, Google Scholar, ScienceDirect, IEEE Xplore, ResearchGate, and Google Patents, covering publications from 2013 to March 2025. Search terms spanned AI-driven formulation design, predictive modelling, ingredient optimisation, toxicity prediction, personalised skincare, and regulatory considerations. Peer-reviewed articles, technical studies, and patents meeting pre-defined inclusion criteria were selected. Results: This review systematically examines AI and ML applications across the cosmetic formulation pipeline from ingredient selection and stability prediction to toxicity screening, safety assessment, and personalised recommendation systems. Discussion: Unlike previous reviews that primarily address diagnostic or imaging applications, this work's particular emphasis is on formulation science: predictive modelling of preservative efficacy, in silico toxicity assessment using quantitative structure-activity relationship (QSAR) and read-across tools, AI-assisted skin analysis, and the algorithmic frameworks underpinning these advances. Comparative discussion of convolutional neural networks (CNN), artificial neural networks (ANN), support vector machines (SVM), random forests, and gradient boosting approaches contextualises their strengths and limitations within cosmetic applications. Conclusion: AI and ML are reshaping cosmetic formulation from an empirical, trial-and-error process into a data-driven, predictive discipline. While challenges related to data quality, algorithmic bias, regulatory harmonisation, and validation remain, the trajectory indicates that AI will become an indispensable partner in designing safer, more effective, and more personalised cosmetic products.
- 24 August 2026
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 25, 1-21
Nano-Magnetism for Precision Neuroscience: Biohybrid Magnetoelectric Nanocarriers as Next-Generation Neural Drug Delivery Platforms
Neuroscience is making tremendous progress toward precision medicine, with nanotechnology playing a critical role in overcoming hurdles to successful brain medication delivery. Nano magnetism, namely biohybrid magnetoelectric nanocarriers (MENs), has emerged as a potential method for targeted and non-invasive medication delivery in neurological illnesses. These nanocarriers possess magnetoelectric properties, enabling stimulus-responsive drug release that is externally controlled. This allows for precise targeting across the blood-brain barrier (BBB), with exceptional spatial and temporal resolution. MENs can deliver neurotherapeutics deep into brain regions by combining magnetic guidance with electrical stimulation, thereby improving treatment outcomes for conditions such as Alzheimer's, Parkinson's, epilepsy, and glioblastoma. Furthermore, their biohybrid nature, which is accomplished by functionalizing nanocarriers with biocompatible coatings, peptides, or membranes produced from neural cells, increases biostability, decreases immune response, and improves neuron targeting. This review investigates the underlying concepts of magnetoelectric nanocarriers, production processes, and interactions with brain tissue. It dives deeper into recent advances in precision neural drug delivery, including the effect of external magnetic and electric fields on regulated drug release, neurostimulation, and neuromodulation. While MENs have tremendous promise, long-term biocompatibility, precise control systems, and regulatory restrictions continue to impede clinical translation. Future research should concentrate on enhancing nanocarrier design, increasing targeting efficiency, and undertaking large-scale preclinical and clinical trials. Magnetoelectric nanocarriers have the potential to transform non-invasive neurotherapeutics by bridging the gap between nano magnetism and neuroscience, resulting in safer and more successful treatment paradigms for complex brain illnesses.
- 24 August 2026
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 25, 1-21
Nano-Magnetism for Precision Neuroscience: Biohybrid Magnetoelectric Nanocarriers as Next-Generation Neural Drug Delivery Platforms
Neuroscience is making tremendous progress toward precision medicine, with nanotechnology playing a critical role in overcoming hurdles to successful brain medication delivery. Nano magnetism, namely biohybrid magnetoelectric nanocarriers (MENs), has emerged as a potential method for targeted and non-invasive medication delivery in neurological illnesses. These nanocarriers possess magnetoelectric properties, enabling stimulus-responsive drug release that is externally controlled. This allows for precise targeting across the blood-brain barrier (BBB), with exceptional spatial and temporal resolution. MENs can deliver neurotherapeutics deep into brain regions by combining magnetic guidance with electrical stimulation, thereby improving treatment outcomes for conditions such as Alzheimer's, Parkinson's, epilepsy, and glioblastoma. Furthermore, their biohybrid nature, which is accomplished by functionalizing nanocarriers with biocompatible coatings, peptides, or membranes produced from neural cells, increases biostability, decreases immune response, and improves neuron targeting. This review investigates the underlying concepts of magnetoelectric nanocarriers, production processes, and interactions with brain tissue. It dives deeper into recent advances in precision neural drug delivery, including the effect of external magnetic and electric fields on regulated drug release, neurostimulation, and neuromodulation. While MENs have tremendous promise, long-term biocompatibility, precise control systems, and regulatory restrictions continue to impede clinical translation. Future research should concentrate on enhancing nanocarrier design, increasing targeting efficiency, and undertaking large-scale preclinical and clinical trials. Magnetoelectric nanocarriers have the potential to transform non-invasive neurotherapeutics by bridging the gap between nano magnetism and neuroscience, resulting in safer and more successful treatment paradigms for complex brain illnesses.
- 21 August 2026
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 26, 1-20
WITHDRAWN: Targeting Metabolic Dysfunctions in Cancer through Nanoparticles: Advances in Therapeutic Delivery
The article has been withdrawn at the request of the authors of the journal Anti-Cancer Agents in Medicinal Chemistry. The authors apologize to the readers of the journal for any inconvenience this may have caused.
- 21 August 2026
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 26, 1-20
WITHDRAWN: Targeting Metabolic Dysfunctions in Cancer through Nanoparticles: Advances in Therapeutic Delivery
The article has been withdrawn at the request of the authors of the journal Anti-Cancer Agents in Medicinal Chemistry. The authors apologize to the readers of the journal for any inconvenience this may have caused.
- 10 August 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32, 1-14
Designing Photostable Hair Dyes with UV-Blocking Properties: Molecular Docking Approaches for Targeted Hair Protection
Hair dyeing is an activity that is here to stay, but the challenge of finding dyes that last longer and provide adequate protection from UV radiation is still an area that is difficult to crack. In this paper, the author attempts to survey the current state of the art in the field of finding photostable dyes that can provide adequate protection from UV radiation by discussing the current understanding of the photodegradation of traditional dyes, the current understanding of the photodegradation of dyes, the current understanding of the impact of UV radiation on keratin, and the current understanding of the use of molecular docking as a tool for predicting the effectiveness of dyes in providing adequate protection from UV radiation. The paper attempts to provide a mechanism for the design of the next generation of hair dyes that can provide adequate protection from UV radiation and safety for the consumer. The author of the paper has taken a novel approach in that, unlike other earlier reviews, the author has focused on molecular docking as the tool for predicting the effectiveness of the next generation of dyes in providing adequate protection from UV radiation, unlike other earlier reviews that have focused on describing the characteristics of the formulation of the dye.
- 10 August 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 32, 1-14
Designing Photostable Hair Dyes with UV-Blocking Properties: Molecular Docking Approaches for Targeted Hair Protection
Hair dyeing is an activity that is here to stay, but the challenge of finding dyes that last longer and provide adequate protection from UV radiation is still an area that is difficult to crack. In this paper, the author attempts to survey the current state of the art in the field of finding photostable dyes that can provide adequate protection from UV radiation by discussing the current understanding of the photodegradation of traditional dyes, the current understanding of the photodegradation of dyes, the current understanding of the impact of UV radiation on keratin, and the current understanding of the use of molecular docking as a tool for predicting the effectiveness of dyes in providing adequate protection from UV radiation. The paper attempts to provide a mechanism for the design of the next generation of hair dyes that can provide adequate protection from UV radiation and safety for the consumer. The author of the paper has taken a novel approach in that, unlike other earlier reviews, the author has focused on molecular docking as the tool for predicting the effectiveness of the next generation of dyes in providing adequate protection from UV radiation, unlike other earlier reviews that have focused on describing the characteristics of the formulation of the dye.
- 16 July 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmacogenomics and Personalized Medicine
- Vol. 23 (1) , 1-16
Machine Learning–Driven Integration of Metal Ion Imbalance Signatures as Emerging Biomarkers for Personalized Diagnosis of Alzheimer’s Disease
Alzheimer’s Disease (AD) is still a significant diagnostic problem because of its prolonged preclinical phase and the relatively low sensitivity of single-modality biomarkers. Recent evidence has pointed to the dysregulation of metal ion homeostasis, specifically iron, copper, zinc, calcium, and aluminium, as a key factor in amyloid aggregation, tau pathology, oxidative stress, and neurodegeneration. This review critically evaluates the role of metal ion imbalance as an underappreciated but biologically relevant biomarker dimension in the diagnosis and classification of AD. We integrate recent progress in neuroimaging with high sensitivity to metal ions, such as quantitative susceptibility mapping and metal-specific PET probes, with blood- and biofluid-based biomarker tests and handheld biosensor platforms for real-time detection. Notably, we emphasize the role of machine learning and artificial intelligence approaches to improve multimodal data fusion for early risk assessment, disease staging, and individualized diagnostics. Imaging, biofluid analysis, and AI modelling findings collectively inform a paradigm shift from single-marker-based methods to system-level, multimodal diagnostic approaches. The results show that combining metal ion biomarkers with AI-assisted imaging and biosensing tools significantly enhances the diagnostic sensitivity and translational value, providing a scalable platform for precision diagnostics and early intervention in Alzheimer’s disease.
- 16 July 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmacogenomics and Personalized Medicine
- Vol. 23 (1) , 1-16
Machine Learning–Driven Integration of Metal Ion Imbalance Signatures as Emerging Biomarkers for Personalized Diagnosis of Alzheimer’s Disease
Alzheimer’s Disease (AD) is still a significant diagnostic problem because of its prolonged preclinical phase and the relatively low sensitivity of single-modality biomarkers. Recent evidence has pointed to the dysregulation of metal ion homeostasis, specifically iron, copper, zinc, calcium, and aluminium, as a key factor in amyloid aggregation, tau pathology, oxidative stress, and neurodegeneration. This review critically evaluates the role of metal ion imbalance as an underappreciated but biologically relevant biomarker dimension in the diagnosis and classification of AD. We integrate recent progress in neuroimaging with high sensitivity to metal ions, such as quantitative susceptibility mapping and metal-specific PET probes, with blood- and biofluid-based biomarker tests and handheld biosensor platforms for real-time detection. Notably, we emphasize the role of machine learning and artificial intelligence approaches to improve multimodal data fusion for early risk assessment, disease staging, and individualized diagnostics. Imaging, biofluid analysis, and AI modelling findings collectively inform a paradigm shift from single-marker-based methods to system-level, multimodal diagnostic approaches. The results show that combining metal ion biomarkers with AI-assisted imaging and biosensing tools significantly enhances the diagnostic sensitivity and translational value, providing a scalable platform for precision diagnostics and early intervention in Alzheimer’s disease.
- 9 July 2026
- Published by Bentham Science Publishers Ltd. in Drug Delivery Letters
- Vol. 16, 1-18
Revolutionizing Alopecia Treatment: Nanostructured Lipid Carriers for Herbal Bioactives in Hair Regeneration
Introduction: Alopecia, affecting millions worldwide, has profound physical and psychosocial impacts. Conventional treatments often face limitations in efficacy, safety, and patient compliance. This review explores nanostructured lipid carriers (NLCs) as advanced delivery systems for herbal bioactives in hair regeneration, aiming to enhance solubility, stability, targeted delivery, and therapeutic efficiency. Methods: A systematic literature search (2015-2025) was conducted using PubMed, Scopus, ScienceDirect, and Google Scholar. Peer-reviewed articles, clinical studies, patents, and regulatory documents were screened for relevance to herbal bioactives in NLC-based formulations for alopecia therapy. Inclusion criteria comprised studies detailing the mechanisms of phytoconstituents, formulation techniques, characterization parameters, and therapeutic outcomes. Results: NLCs demonstrated superior entrapment efficiency (≥80%), nanoscale size (120-500 nm), sustained release, and enhanced follicular targeting compared to conventional carriers. Phytoconstituents such as ginsenosides, quercetin, EGCG, curcumin, and β-sitosterol promoted hair growth via Wnt/β-catenin, PI3K/Akt, and anti-inflammatory pathways. Clinical and preclinical data indicated up to 7-fold greater skin deposition, increased hair density, and prolonged anagen phase with reduced irritation potential. Discussion: The synergistic integration of NLCs and herbal actives addresses major formulation challenges, including poor solubility, instability, and limited follicular penetration. Comparative analysis revealed NLCs outperforming SLNs, liposomes, and ethosomes in stability, drug loading, and follicular targeting. Limitations include variability in herbal composition, need for long-term safety data, and lack of large-scale clinical trials. Conclusion: NLC-based herbal formulations present a promising, biocompatible, and targeted strategy for alopecia management. Future directions should focus on AI-driven formulation optimization, gender-specific therapies, green manufacturing, and rigorous clinical validation to accelerate translation from laboratory to market.
- 9 July 2026
- Published by Bentham Science Publishers Ltd. in Drug Delivery Letters
- Vol. 16, 1-18
Revolutionizing Alopecia Treatment: Nanostructured Lipid Carriers for Herbal Bioactives in Hair Regeneration
Introduction: Alopecia, affecting millions worldwide, has profound physical and psychosocial impacts. Conventional treatments often face limitations in efficacy, safety, and patient compliance. This review explores nanostructured lipid carriers (NLCs) as advanced delivery systems for herbal bioactives in hair regeneration, aiming to enhance solubility, stability, targeted delivery, and therapeutic efficiency. Methods: A systematic literature search (2015-2025) was conducted using PubMed, Scopus, ScienceDirect, and Google Scholar. Peer-reviewed articles, clinical studies, patents, and regulatory documents were screened for relevance to herbal bioactives in NLC-based formulations for alopecia therapy. Inclusion criteria comprised studies detailing the mechanisms of phytoconstituents, formulation techniques, characterization parameters, and therapeutic outcomes. Results: NLCs demonstrated superior entrapment efficiency (≥80%), nanoscale size (120-500 nm), sustained release, and enhanced follicular targeting compared to conventional carriers. Phytoconstituents such as ginsenosides, quercetin, EGCG, curcumin, and β-sitosterol promoted hair growth via Wnt/β-catenin, PI3K/Akt, and anti-inflammatory pathways. Clinical and preclinical data indicated up to 7-fold greater skin deposition, increased hair density, and prolonged anagen phase with reduced irritation potential. Discussion: The synergistic integration of NLCs and herbal actives addresses major formulation challenges, including poor solubility, instability, and limited follicular penetration. Comparative analysis revealed NLCs outperforming SLNs, liposomes, and ethosomes in stability, drug loading, and follicular targeting. Limitations include variability in herbal composition, need for long-term safety data, and lack of large-scale clinical trials. Conclusion: NLC-based herbal formulations present a promising, biocompatible, and targeted strategy for alopecia management. Future directions should focus on AI-driven formulation optimization, gender-specific therapies, green manufacturing, and rigorous clinical validation to accelerate translation from laboratory to market.
- 3 July 2026
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 17 (7) , 675-692
Capsaicin and diclofenac coloaded nanoemulsion gel optimized by quality by design approach of for the treatment of rheumatoid arthritis
1. Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder characterized by persistent synovial inflammation, infiltration of immune cells, and progressive destruction of cartilage ...
- 3 July 2026
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 17 (7) , 675-692
Capsaicin and diclofenac coloaded nanoemulsion gel optimized by quality by design approach of for the treatment of rheumatoid arthritis
1. Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder characterized by persistent synovial inflammation, infiltration of immune cells, and progressive destruction of cartilage ...
- 25 May 2026
- Published by Bentham Science Publishers Ltd. in Current Neurovascular Research
- Vol. 23, 1-8
Development, Optimization, and Characterization of Donepezil Hydrochloride-loaded Emulsomes with Nigella Sativa Oil for the Treatment of Alzheimer’s Disease
Introduction: Alzheimer’s disease is a progressive neurodegenerative disorder where conventional oral delivery of donepezil hydrochloride is limited by poor bioavailability and restricted brain access due to the blood–brain barrier. This study aims to develop an alternative nanocarrier-based delivery system to enhance therapeutic efficacy. Method: Trestearin, phosphatidylcholine, and cholesterol formed a solid lipid core that was used to make emulsomes. TEM was used to characterize emulsomes, while FTIR spectroscopy was used for compatibility tests. The formulation was optimized using the 3-factor, 3-level Central Composite Design. Result: The optimized emulsome formulation demonstrated a stable formulation with a mean particle diameter of 124 ± 3.25 nm, an entrapment efficiency of 74 ± 0.67%, a PDI of 0.209 ± 0.03, with a zeta potential of -0.130 mV. In vitro release study demonstrated a consistent drugrelease pattern, with 84 ± 1.24% of the medication released during the investigation. Discussion: Based on insights from the thesis, emulsomes incorporating Nigella sativa oil show enhanced neuroprotective potential due to the antioxidant and anti-inflammatory actions of thymoquinone. The intranasal route further supports improved brain targeting by bypassing the blood–brain barrier. The consistency of particle size, strong entrapment efficiency, and sustained drug release align with the reported advantages of emulsome-based formulations discussed in the thesis, reinforcing their promise as an effective approach for Alzheimer's treatment. Conclusion: The central composite design optimization ensures a stable and effective delivery system for the donepezil hydrochloride-loaded emulsomes containing Nigella sativa oil with great potential for novel drug delivery in Alzheimer's disease.
- 25 May 2026
- Published by Bentham Science Publishers Ltd. in Current Neurovascular Research
- Vol. 23, 1-8
Development, Optimization, and Characterization of Donepezil Hydrochloride-loaded Emulsomes with Nigella Sativa Oil for the Treatment of Alzheimer’s Disease
Introduction: Alzheimer’s disease is a progressive neurodegenerative disorder where conventional oral delivery of donepezil hydrochloride is limited by poor bioavailability and restricted brain access due to the blood–brain barrier. This study aims to develop an alternative nanocarrier-based delivery system to enhance therapeutic efficacy. Method: Trestearin, phosphatidylcholine, and cholesterol formed a solid lipid core that was used to make emulsomes. TEM was used to characterize emulsomes, while FTIR spectroscopy was used for compatibility tests. The formulation was optimized using the 3-factor, 3-level Central Composite Design. Result: The optimized emulsome formulation demonstrated a stable formulation with a mean particle diameter of 124 ± 3.25 nm, an entrapment efficiency of 74 ± 0.67%, a PDI of 0.209 ± 0.03, with a zeta potential of -0.130 mV. In vitro release study demonstrated a consistent drugrelease pattern, with 84 ± 1.24% of the medication released during the investigation. Discussion: Based on insights from the thesis, emulsomes incorporating Nigella sativa oil show enhanced neuroprotective potential due to the antioxidant and anti-inflammatory actions of thymoquinone. The intranasal route further supports improved brain targeting by bypassing the blood–brain barrier. The consistency of particle size, strong entrapment efficiency, and sustained drug release align with the reported advantages of emulsome-based formulations discussed in the thesis, reinforcing their promise as an effective approach for Alzheimer's treatment. Conclusion: The central composite design optimization ensures a stable and effective delivery system for the donepezil hydrochloride-loaded emulsomes containing Nigella sativa oil with great potential for novel drug delivery in Alzheimer's disease.